Results 1 to 10 of about 360,515 (329)

Can propylthiouracil induce autoimmune-related immunotoxicity? [PDF]

open access: yesVojnosanitetski Pregled, 2022
Introduction. The use of propylthiouracil can be associated with mild adverse reactions, but severe complications such as agranulocytosis and vasculitis can also be seen.
Bajkin Ivana   +4 more
doaj   +1 more source

Mediastinal neoplasms in patients with Graves disease: a possible link between sustained hyperthyroidism and thymic neoplasia? [PDF]

open access: yes, 2012
Background Anterior mediastinal masses are a rare but well documented finding in Graves disease. The vast majority of these lesions represents benign thymic hypertrophy and regress after treatment of the hyperthyroidism.
Boyd, Jonathan D, Juskevicius, Ridas
core   +2 more sources

Treatment for Condyloma Acuminatum with Graves’ disease [PDF]

open access: yes, 2016
SAS Publisher's journals are open access journals.A rare case of external genital condylomata acuminatum with Graves’ disease was reported. The cauliflower warts were observed on glans penis and foreskin of a 40-year-old man, who had typical Graves ...
Ji Luo, Nian, Tang, Ning
core   +1 more source

The Pecularities of Correlation Between Insulin Resistance, Carbohydrate and Lipid Metabolism Indices in Patients with Graves'disease [PDF]

open access: yes, 2017
Aim. The number of patients with endocrine disorders in the world, in particular, Graves' disease is continuously increasing. Recent studies have determined the fact of insulin resistance in thyroid disorders.
Kikhtyak, O. (Olesya)   +2 more
core   +2 more sources

Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis. [PDF]

open access: yes, 1996
The etiology of Riedel's invasive fibrous thyroiditis (IFT) has remained obscure. This rare disorder has been confused in the past with the more common fibrous variant of Hashimoto's disease.
Bahn, R. S.   +4 more
core   +1 more source

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy

open access: yesThyroid Research, 2019
Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska   +2 more
doaj   +1 more source

New Method of Calculating the Excess Amount of Soft Tissues of the Orbit in Patients with Endocrine Ophthalmopathy when Planning Operations

open access: yesOftalʹmologiâ, 2019
Objective. Improving the efficiency of the operation of orbit decompression in patients with endocrine ophthalmopathy through the development of a new method for calculating an excess volume of soft tissues of the orbit. Patients and methods.
D. V. Davydov   +4 more
doaj   +1 more source

Orbital lymphoma associated with Graves’ disease: A case report [PDF]

open access: yesVojnosanitetski Pregled, 2014
Introduction. The presence of bilateral exophthalmos and palpebral, periorbital edema associated with hyperthyroidism is most often considered as an initial sign of Graves’ ophthalmopathy.
Hajduković Zoran   +4 more
doaj   +1 more source

Comparison of Thyroid Size-Specific Radioiodine Dose and New Modified Dose Calculation in the Treatment of Graves’ Disease [PDF]

open access: yesEndocrinology and Metabolism
Background Previous studies of fixed-dose radioiodine therapy (RIT) for Graves’ disease (GD) have utilized a variety of techniques and reported differing success rates.
Alisara Wongsuttilert   +3 more
doaj   +1 more source

Patients' perceptions and views of surgery and radioiodine ablation in the definitive management of Graves' disease. [PDF]

open access: yes, 2017
BACKGROUND: Patients' perceptions and preferences influence the choice of radioiodine ablation (RIA) or surgery in the definitive management of Graves' disease.
Allahabadia, A.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy